Forefront Analytics’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Forefront Analytics's PFE Position: Q2 2026 in Review
Forefront Analytics increased its Pfizer (PFE) stake by 39% in Q2 2026, buying an estimated $134K and bringing the position to 18,210 shares worth $438K. The position accounts for 0.48% of the portfolio, ranked #22.
Forefront Analytics first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $476K in Q4 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Forefront Analytics held 18,210 shares of Pfizer worth $438K as of Q2 2026.
- Forefront Analytics bought 5,120 Pfizer shares in Q2 2026, an estimated $134K.
- Pfizer made up 0.48% of Forefront Analytics's portfolio in Q2 2026, its #22 holding.
- Forefront Analytics first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Forefront Analytics's Pfizer position peaked at $476K in Q4 2025.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.